SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:su-183146"
 

Sökning: onr:"swepub:oai:DiVA.org:su-183146" > The effect of levos...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004198naa a2200457 4500
001oai:DiVA.org:su-183146
003SwePub
008200702s2020 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:143676768
024a https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-1831462 URI
024a https://doi.org/10.1016/j.resuscitation.2020.02.0322 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1436767682 URI
040 a (SwePub)sud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Rysz, Susanneu Karolinska Institutet4 aut
2451 0a The effect of levosimendan on survival and cardiac performance in an ischemic cardiac arrest model - A blinded randomized placebo -controlled study in swine
264 1b Elsevier BV,c 2020
338 a print2 rdacarrier
520 a Background: Survival after out-of-hospital cardiac arrest remains poor. Levosimendan could be a new intervention in this setting. Therefore, we conducted a blinded, placebo controlled randomized study investigating the effects of levosimendan on survival and cardiac performance in an ischemic cardiac arrest model in swine. Methods: Twenty-four anesthetised swines underwent experimentally-induced acute myocardial infarction and ventricular fibrillation. At the start of CPR, a bolus dose of levosimendan (12 μg kg-1) or placebo was given followed by a 24-h infusion (0.2 μg kg-1 min-1) after return of spontaneously circulation. Animals were evaluated by risk of death, post-resuscitation hemodynamics and infarction size by magnetic resonance imaging (MRI) up to 32 h post arrest. Results: Spontaneous circulation was restored in all (12/12) animals in the levosimendan group compared to two thirds (8/12) in the placebo group (P = 0.09). Protocol survival was higher for the levosimendan group (P = 0.02) with an estimated 88% lower risk of death compared to placebo (hazard ratio [95% confidence interval] 0.12 [0.01-0.96], P = 0.046). Cardiac output (CO) recovered 40% faster during the first hour of the intensive care period for the levosimendan group (difference 0.13 [0.01-0.26] L min-1P = 0.04). The placebo group required higher inotropic support during the intensive care period which masked an even bigger recovery in CO in the levosimendan group (58%). The MRI showed no difference in myocardial scar size or in myocardial area at risk. Conclusions: Levosimendan given intra-arrest and during the first 24-h of post-resuscitation care improved survival and cardiac performance in this ischemic cardiac arrest model. Institutional Protocol Number; KERIC 5.2.18-14933.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Anestesi och intensivvård0 (SwePub)302012 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Anesthesiology and Intensive Care0 (SwePub)302012 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
700a Lundberg, Johanu Karolinska Institutet4 aut
700a Nordberg, Peru Karolinska Institutet4 aut
700a Eriksson, Helenu Stockholms universitet,Sociologiska institutionen4 aut0 (Swepub:su)heler
700a Wieslander, Bjornu Karolinska Institutet4 aut
700a Lundin, Magnusu Karolinska Institutet4 aut
700a Fyrdahl, Alexanderu Karolinska Institutet4 aut
700a Pernow, Johnu Karolinska Institutet4 aut
700a Ugander, Martinu Karolinska Institutet4 aut
700a Djarv, Thereseu Karolinska Institutet4 aut
700a Fagerlund, Malin Jonssonu Karolinska Institutet4 aut
710a Karolinska Institutetb Sociologiska institutionen4 org
773t Resuscitationd : Elsevier BVg 150, s. 113-120q 150<113-120x 0300-9572x 1873-1570
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-183146
8564 8u https://doi.org/10.1016/j.resuscitation.2020.02.032
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:143676768

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy